Magnolia Capital Management’s AbbVie ABBV Stock Holding History

Magnolia Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$930K	Buy	3,695 +10	+0.3%	+$2.15K	0.64%	28
2026 Q1	$801K	Hold	3,685	–	–	0.54%	40
2025 Q4	$842K	Hold	3,685	–	–	0.63%	27
2025 Q3	$853K	Hold	3,685	–	–	0.65%	27
2025 Q2	$684K	Hold	3,685	–	–	0.55%	36
2025 Q1	$772K	Hold	3,685	–	–	0.66%	31
2024 Q4	$655K	Hold	3,685	–	–	0.52%	40
2024 Q3	$728K	Hold	3,685	–	–	0.58%	36
2024 Q2	$632K	Hold	3,685	–	–	0.53%	41
2024 Q1	$671K	Hold	3,685	–	–	0.57%	37
2023 Q4	$571K	Hold	3,685	–	–	0.52%	38
2023 Q3	$549K	Hold	3,685	–	–	0.53%	42
2023 Q2	$496K	Sell	3,685 -1,815	-33%	-$266K	0.45%	49
2023 Q1	$877K	Hold	5,500	–	–	0.82%	29
2022 Q4	$889K	Hold	5,500	–	–	0.87%	27
2022 Q3	$738K	Hold	5,500	–	–	0.76%	28
2022 Q2	$842K	Hold	5,500	–	–	0.82%	28
2022 Q1	$892K	Hold	5,500	–	–	0.74%	28
2021 Q4	$745K	Hold	5,500	–	–	0.59%	38
2021 Q3	$593K	Buy	+5,500	New	+$628K	0.51%	43

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Magnolia Capital Management's ABBV Position: Q2 2026 in Review

Magnolia Capital Management increased its AbbVie (ABBV) stake by 0.27% in Q2 2026, buying an estimated $2.15K and bringing the position to 3,695 shares worth $930K. The position accounts for 0.64% of the portfolio, ranked #28.

Magnolia Capital Management first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Magnolia Capital Management held 3,695 shares of AbbVie worth $930K as of Q2 2026.
Magnolia Capital Management bought 10 AbbVie shares in Q2 2026, an estimated $2.15K.
AbbVie made up 0.64% of Magnolia Capital Management's portfolio in Q2 2026, its #28 holding.
Magnolia Capital Management first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Magnolia Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.